Clover Flex Sihuan Pharmaceutical's exclusive agent for botulinum toxin Letibao is approved for marketing by NMPA Vertex's Kalydeco for cystic fibrosis is close to approval in the EU Two imported new ...

INR:6560. blackjack real Bayer acquires AskBio for $4 billion to expand cell and gene therapy pipeline Vertex's Kalydeco for cystic fibrosis is close to approval i ...

INR:8074. france vs austria betting tips Science: There is scientific evidence that staying up late makes you stupid!

The top 10 pharmaceutical stocks are released! Hengrui Medicine aims to hit a market value of 370 billion yuan ASH | BTK inhibitor development trends: Eli Lilly, BeiGene, and AZ announce clinical resu ...

Nature: Large-scale screening discovered 21 existing anti-new coronavirus drugs! Sanofi expands collaboration with US$2.3 billion to develop mRNA vaccines for infectious diseases! Vertex's Kalydeco fo ...

INR:3725. across the unlverse fiona apple Will the next round of centralized procurement include Caronin, Enbipu, and Shupushen? "Fake stock" ST K ...

The medicine hit its primary endpoint of a decrease in the average daily leg pain intensity as measured by the Numeric Pain ...

INR:6273. lakshmi lottery GSK's two-drug HIV therapy to receive priority review The first peanut allergy immunotherapy! Aimmune's desensitization therapy Palforzi ...

INR:0875. play online The surge in prices of vaccines and testing reagents was due to the "Qingdao epidemic breaking out again" The final verdict of "Li Jianxue medic ...

According to Vertex Pharmaceuticals, approximately 300 additional people with CF are now eligible to receive treatment.

The Food and Drug Administration (FDA) has approved Alyftrek ™ (vanzacaftor/tezacaftor/deutivacaftor) for the treatment of cystic fibrosis (CF) in patients aged 6 years and older who have at least one ...

Vertex Pharmaceuticals (NASDAQ: VRTX) fell by 13% on Dec. 19, when the rare-disease drug developer reported some lackluster ...